US dairy giant Dean Foods has abandoned a potential takeover of trans-Tasman dairy company a2 Milk.
Dean lobbed an expression of interest into a2 with Australian breakfast cereal and snack company Freedom Foods in June. Freedom confirmed on Monday that the pair had ditched takeover plans.
“The company and Dean Foods have ceased detailed discussions in relation to a2,” Freedom said.
Fairfax Media revealed earlier in August that insider trading investigation into Dean by the US regulator had derailed the takeover plans. The investigation reportedly involved golfer Phil Mickelson and professional sports gambler William T. Walters.
Dean has also refused to explain the resignation of its chairman Tom C. Davis, who left soon after the company revealed it was being investigated.
A2 Milk’s board rejected the offer from Dean and Freedom, which is controlled by the billionaire Perich family and is a2’s biggest shareholder, saying it was not compelling enough.
The three parties had not spoken in the month since, and Freedom was believed to be underwhelmed by a2’s full-year financial results, despite it reporting a 40 per cent surge in revenue and being broadly in line with analysts’ estimates.
Freedom posted on Monday a 366.8 per cent jump in net profit to $56.6 million for the year ending June 30.
Chief executive Rory Macleod said this included “an unrealised post-tax fair-value gain of $51.96 million” after the company signalled earlier that it wanted to sell its 19 per cent stake in a2 Milk.
On an underlying basis, Freedom’s net profit fell 60.3 per cent to $4.9 million. Revenue, meanwhile, firmed 4.1 per cent to $91.5 million.
Mr Macleod said Freedom had merely reclassified its a2 stake for accounting reasons, after it lost one of its two board seats following the resignation of Perry Gunner at the milk processor’s annual meeting in November 2014. He said it did not mean Freedom would literally sell its holding.
“The strategic investment in the a2 Milk Company provides the company [Freedom Foods] and its shareholders a potentially significant value-creation opportunity,” he said.
“We will continue to review all our options with regard to the a2 investment, including evaluating the benefits of maintaining a strategic stake in a2.”
Source: Sydney Morning Herald
Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.
US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.
Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.